# Prevention and Control of Neoplasms Associated With HPV in High-risk Groups in Mexico City: The Condesa Study

> **NCT05149248** · PHASE2,PHASE3 · COMPLETED · sponsor: **Instituto Nacional de Salud Publica, Mexico** · enrollment: 6000 (actual)

## Conditions studied

- Cancer of Cervix

## Interventions

- **BIOLOGICAL:** Gardasil® [Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant vaccine]
- **BIOLOGICAL:** Two dose
- **OTHER:** Control group
- **BIOLOGICAL:** 2 dose vaccination over 6 month

## Key facts

- **NCT ID:** NCT05149248
- **Lead sponsor:** Instituto Nacional de Salud Publica, Mexico
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-30
- **Primary completion:** 2019-10-30
- **Final completion:** 2019-11-28
- **Target enrollment:** 6000 (ACTUAL)
- **Last updated:** 2021-12-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05149248

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05149248, "Prevention and Control of Neoplasms Associated With HPV in High-risk Groups in Mexico City: The Condesa Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05149248. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*